[Liver fibrosis. 1 (author's transl)] - PubMed (original) (raw)
[Article in German]
- PMID: 7456564
[Liver fibrosis. 1 (author's transl)]
[Article in German]
E G Hahn et al. Z Gastroenterol. 1980 Sep.
Abstract
The mortality of liver cirrhosis has doubled during the past two decades and is still increasing in most of the European countries. One important feature and precursor of liver cirrhosis is liver fibrosis. Its aetiology includes a wide spectrum of well known causes, in Europe most frequently alcohol, virus infection, and chemical agents. The pathomechanism of liver fibrosis is unknown. Diagnostic and therapeutic approaches for early detection and treatment have been recently developed applying the results of pathobiochemical, cellular and clinical research. The composition of the increased hepatic connective tissue suggests the involvement of myofibroblasts and shows similarities to atherosclerotic plaques and lung fibrosis. The isolation, purification and cultivation of cells from liver biopsies offers new avenues for the study of fibroplastic cells. Clinical studies are now facilitated, since products of the collagen synthetic pathway -- procollagen peptides--can be measured in serum with a sensitive radioimmunoassay. Further prospective studies including additional parameters of fibroplasia, such as N-acetyl-beta-D-glucosaminidase, lysyloxidase and prolylhydroxylase will have to demonstrate the diagnostic value of such methods. Even today, they should be applied in therapeutic trials of chronic fibrotic liver diseases. Better knowledge of the molecular regulation of connective tissue, and the use of new animal models and cellular system support a successful search for new therapeutic tools. Above all, limitation of alcohol consumption, vaccination for viral hepatitis and elimination of chemical agents offer the prevention of fibrosis, which calls for major efforts on a nation-wide scale.
Similar articles
- [Liver fibrosis. 2].
Hahn EG, Ott U, Martini GA. Hahn EG, et al. Z Gastroenterol. 1980 Oct;18(10):507-23. Z Gastroenterol. 1980. PMID: 6109405 Review. German. - [Hepatic fibrosis--mechanism, dynamics and clinical consequences (author's transl)].
Popper H. Popper H. Leber Magen Darm. 1978 Apr;8(2):65-72. Leber Magen Darm. 1978. PMID: 204839 German. - [Progress in the diagnosis of chronic liver disease: diagnostic activity in liver fibrosis and cirrhosis].
Pott G, Gerlach U. Pott G, et al. Leber Magen Darm. 1982 Aug;12(4):141-4. Leber Magen Darm. 1982. PMID: 6752610 Review. German. - Cirrhosis--can we reverse hepatic fibrosis?
Tangkijvanich P, Yee HF Jr. Tangkijvanich P, et al. Eur J Surg Suppl. 2002;(587):100-12. Eur J Surg Suppl. 2002. PMID: 16144208 Review. - [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
Wasmuth HE, Lammert F, Matern S. Wasmuth HE, et al. Med Klin (Munich). 2003 Dec 15;98(12):754-62. doi: 10.1007/s00063-003-1324-3. Med Klin (Munich). 2003. PMID: 14685677 Review. German.
Cited by
- Hepatic fibrosis--current concepts of pathogenesis and therapy.
Högemann B, Domschke W. Högemann B, et al. Gastroenterol Jpn. 1993 Aug;28(4):570-9. Gastroenterol Jpn. 1993. PMID: 8375627 Review. No abstract available. - Connective tissue components of the normal and fibrotic human liver. II. Clinical aspects.
Pott G, Rauterberg J, Voss B, Gerlach U. Pott G, et al. Klin Wochenschr. 1982 Jan 4;60(1):1-7. doi: 10.1007/BF01721581. Klin Wochenschr. 1982. PMID: 7043067 Review. - Myofibroblasts in focal nodular hyperplasia of the liver.
Callea F, Mebis J, Desmet VJ. Callea F, et al. Virchows Arch A Pathol Anat Histol. 1982;396(2):155-66. doi: 10.1007/BF00431238. Virchows Arch A Pathol Anat Histol. 1982. PMID: 6889782 - Desmoplastic breast carcinoma as a source of human myofibroblasts.
Barsky SH, Green WR, Grotendorst GR, Liotta LA. Barsky SH, et al. Am J Pathol. 1984 Jun;115(3):329-33. Am J Pathol. 1984. PMID: 6329001 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous